EUVIMEDEUVIMED entdecken
Systematische Übersicht

Immunotherapy in the Management of Sinonasal Mucosal Melanoma: A Systematic Review

Anthony Tang, Suchet Taori, Sophia Dang iD, Paul A Gardner iD, Georgios A Zenonos, Diwakar Davar, Edward C Kuan, Carl H Snyderman iD, Eric W Wang iD, Garret Choby iD

Otolaryngology–Head and Neck Surgery · 2024-08 · 171 (2) · 368-380

DOI: 10.1002/ohn.790 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Otolaryngology–Head and Neck Surgery, online erschienen am 30.04.2024. Verfasst von Anthony Tang und 9 weiteren Autor:innen. Beteiligte Einrichtung: University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA. Hauptthemen laut MEDLINE: Melanoma, Immunotherapy, Paranasal Sinus Neoplasms. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 79 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The aim of this work is to comprehensively review and synthesize the literature related to sinonasal mucosal melanoma (SNMM) treatment with immunotherapy, including potentially targetable genetic mutations, survival outcomes, and adverse events. Data Sources Embase, Cochrane, Scopus, and Web of Science. Review Methods The study protocol was designed according to Preferred Reporting Items for Systematic Reviews and Meta‐analysis statement. Databases were searched from inception through May 23, 2023.

Results

A total of 42 studies met inclusion criteria. Twenty‐four of the included studies reported genetic mutations for a combined 787 patients with SNMM. 8.1% (95% confidence interval, CI: 7.6‐8.6), 18.9% (95% CI: 18.1‐19.8), and 8.5% (95% CI: 8.1‐9.0) of reported patients were positive for BRAF , NRAS , and KIT mutations, respectively. The presence of brisk tumor‐infiltrating lymphocytes was associated with improved recurrence‐free survival and overall survival (OS). Six studies reported a combined 5‐year OS after adjuvant immunotherapy treatment of 42.6% (95% CI: 39.4‐45.8). Thirteen studies encompassing 117 patients reported adjuvant or salvage immune checkpoint inhibitor (ICI) immunotherapy response rates: 40.2% (95% CI: 36.8‐43.6) had a positive response (tumor volume reduction or resolution). Eleven studies reported direct comparisons between SNMM patients treated with or without immunotherapy; the majority (7/11) reported survival benefit for their entire cohort or select subgroups of SNMM patients. With the transition to modern ICIs, there is a stronger trend toward survival improvement with adjuvant ICI. Tumors with Ki67

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaImmunotherapyParanasal Sinus NeoplasmsHumansNasal MucosaMutationImmune Checkpoint Inhibitors

Stichwörter der Autor:innen

biomarkersgenetic mutationsimmunotherapysinonasal mucosal melanomatargeted therapy

Substanzen

Immune Checkpoint Inhibitors

Autor:innen und Institutionen

  • University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
  • Department of Otolaryngology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
  • Department of Neurological Surgery, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
  • Division of Hematology/Oncology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
  • Department of Otolaryngology-Head and Neck Surgery and Neurological Surgery, University of California Irvine, Orange, California, USA.

ORCID-Profile: Sophia Dang, Paul A Gardner, Carl H Snyderman, Eric W Wang, Garret Choby

Zitieren

APA

Tang, A., Taori, S., Dang, S., Gardner, P. A., Zenonos, G. A., Davar, D., Kuan, E. C., Snyderman, C. H., Wang, E. W., & Choby, G. (2024). Immunotherapy in the Management of Sinonasal Mucosal Melanoma: A Systematic Review. Otolaryngology–Head and Neck Surgery, 171(2), 368-380. https://doi.org/10.1002/ohn.790

Vancouver

Tang A, Taori S, Dang S, Gardner PA, Zenonos GA, Davar D, et al. Immunotherapy in the Management of Sinonasal Mucosal Melanoma: A Systematic Review. Otolaryngology–Head and Neck Surgery. 2024;171(2):368-380. doi:10.1002/ohn.790

BibTeX
@article{Tang2024,
  author = {Tang, Anthony and Taori, Suchet and Dang, Sophia and Gardner, Paul A and Zenonos, Georgios A and Davar, Diwakar and Kuan, Edward C and Snyderman, Carl H and Wang, Eric W and Choby, Garret},
  title = {Immunotherapy in the Management of Sinonasal Mucosal Melanoma: A Systematic Review},
  journal = {Otolaryngology–Head and Neck Surgery},
  year = {2024},
  volume = {171},
  number = {2},
  pages = {368--380},
  doi = {10.1002/ohn.790}
}
Kostenlos starten →